Logo image of APPH

APPHARVEST INC (APPH) Stock Fundamental Analysis

NASDAQ:APPH - Nasdaq - US03783T1034 - Common Stock - Currency: USD

0.0666  -0.01 (-16.02%)

After market: 0.069 +0 (+3.6%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to APPH. APPH was compared to 90 industry peers in the Food Products industry. APPH may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, APPH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year APPH has reported negative net income.
In the past year APPH has reported a negative cash flow from operations.
APPH Yearly Net Income VS EBIT VS OCF VS FCFAPPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -100M -200M -300M -400M

1.2 Ratios

The profitability ratios for APPH are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APPH Yearly ROA, ROE, ROICAPPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -20 -40 -60

1.3 Margins

APPH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APPH Yearly Profit, Operating, Gross MarginsAPPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 -500 -1K -1.5K

2

2. Health

2.1 Basic Checks

APPH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, APPH has more shares outstanding
The debt/assets ratio for APPH is higher compared to a year ago.
APPH Yearly Shares OutstandingAPPH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M 80M 100M
APPH Yearly Total Debt VS Total AssetsAPPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -1.37, we must say that APPH is in the distress zone and has some risk of bankruptcy.
APPH's Altman-Z score of -1.37 is on the low side compared to the rest of the industry. APPH is outperformed by 82.22% of its industry peers.
APPH has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.06, APPH is doing worse than 78.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z -1.37
ROIC/WACCN/A
WACC4.5%
APPH Yearly LT Debt VS Equity VS FCFAPPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 200M -200M -400M

2.3 Liquidity

A Current Ratio of 2.25 indicates that APPH has no problem at all paying its short term obligations.
APPH has a better Current ratio (2.25) than 65.56% of its industry peers.
A Quick Ratio of 1.92 indicates that APPH should not have too much problems paying its short term obligations.
APPH has a better Quick ratio (1.92) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.92
APPH Yearly Current Assets VS Current LiabilitesAPPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 50M 100M 150M

4

3. Growth

3.1 Past

APPH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.38%.
The Revenue has grown by 88.33% in the past year. This is a very strong growth!
EPS 1Y (TTM)-10.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.33%
Revenue 1Y (TTM)88.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%151.96%

3.2 Future

The Earnings Per Share is expected to grow by 16.23% on average over the next years. This is quite good.
APPH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 101.36% yearly.
EPS Next Y20.76%
EPS Next 2Y23.95%
EPS Next 3Y16.23%
EPS Next 5YN/A
Revenue Next Year188.17%
Revenue Next 2Y164.55%
Revenue Next 3Y101.37%
Revenue Next 5YN/A

3.3 Evolution

APPH Yearly Revenue VS EstimatesAPPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
APPH Yearly EPS VS EstimatesAPPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for APPH. In the last year negative earnings were reported.
Also next year APPH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APPH Price Earnings VS Forward Price EarningsAPPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APPH Per share dataAPPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

APPH's earnings are expected to grow with 16.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3Y16.23%

0

5. Dividend

5.1 Amount

APPH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

APPHARVEST INC

NASDAQ:APPH (8/1/2023, 8:00:01 PM)

After market: 0.069 +0 (+3.6%)

0.0666

-0.01 (-16.02%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-09 2023-08-09/amc
Earnings (Next)11-06 2023-11-06/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners16.07%
Ins Owner Change0%
Market Cap10.33M
Analysts45.71
Price Target0.77 (1056.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.42%
Min EPS beat(2)-17.65%
Max EPS beat(2)-3.2%
EPS beat(4)2
Avg EPS beat(4)2.37%
Min EPS beat(4)-17.65%
Max EPS beat(4)26.07%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)8.92%
Min Revenue beat(2)0.69%
Max Revenue beat(2)17.15%
Revenue beat(4)2
Avg Revenue beat(4)-14.45%
Min Revenue beat(4)-57.19%
Max Revenue beat(4)17.15%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-53.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.2%
EPS NY rev (1m)-25.33%
EPS NY rev (3m)-25.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.57%
Revenue NY rev (1m)-4.43%
Revenue NY rev (3m)-4.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB 0.04
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-1.53
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.14
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 732.97%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.92
Altman-Z -1.37
F-Score4
WACC4.5%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.33%
EPS Next Y20.76%
EPS Next 2Y23.95%
EPS Next 3Y16.23%
EPS Next 5YN/A
Revenue 1Y (TTM)88.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%151.96%
Revenue Next Year188.17%
Revenue Next 2Y164.55%
Revenue Next 3Y101.37%
Revenue Next 5YN/A
EBIT growth 1Y10.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.35%
EBIT Next 3Y24.42%
EBIT Next 5YN/A
FCF growth 1Y-38.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-128.06%
OCF growth 3YN/A
OCF growth 5YN/A